Status:
COMPLETED
Hemostatic Variables In Snakebite Study
Lead Sponsor:
Jubilee Mission Medical College and Research Institute
Conditions:
Snake Bites
Coagulopathy, Consumption
Eligibility:
All Genders
Brief Summary
Background Novelty The global assays of coagulation, namely the viscoelastometric tests and clot waveform has never been studied in detail before in snakebite victims. The pathophysiology of VICC in...
Detailed Description
The problem: Snakebite is a neglected disease of the poor in India. Nearly 50,000 individuals die of snake bite every year in the country, making it the region with most number of snakebite related d...
Eligibility Criteria
Inclusion
- All patients with history suggestive of snakebite presenting within 6 hours of snakebite AND
- All providing a written informed consent and/or assent
Exclusion
- All patients of stings or bites other than snakes
- All patients who received antivenom or blood products at another institute
- All patients with known hematological malignancies, coagulation disorders, chronic liver or renal failure.
- All patients known to be on warfarin, heparin or any newer oral or injectable anticoagulants
- All withdrawing a consent later on, or withdrawing assent later on-
Key Trial Info
Start Date :
March 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 9 2023
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04520282
Start Date
March 15 2022
End Date
August 9 2023
Last Update
March 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jubilee Mission Medical College and Research Institute
Thrissur, Kerala, India, 680005